Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort

scientific article published on 10 March 2008

Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.YPMED.2008.02.023
P698PubMed publication ID18456313

P2093author name stringS Czernichow
A-C Vergnaud
S Hercberg
P Galan
S Bertrais
P2860cites workPrediction of Coronary Heart Disease Using Risk Factor CategoriesQ22241923
Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort studyQ24630111
Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart surveyQ28186036
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyQ28281870
Mortality by cause for eight regions of the world: Global Burden of Disease StudyQ29615121
A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart StudyQ30713072
Prediction of first coronary events with the Framingham score: a systematic reviewQ33282507
A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItaminQ34067086
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and mineralsQ34370181
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectQ34534248
By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in diseaseQ35771476
Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health prospective cohort study.Q35772030
Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA StudyQ36768750
21 year trends in incidence of myocardial infarction and mortality from coronary disease in middle-ageQ39435223
Use and misuse of the receiver operating characteristic curve in risk predictionQ40241086
The Framingham prediction rule is not valid in a European population of treated hypertensive patientsQ44164785
Alcohol consumption and insulin resistance syndrome parameters: associations and evolutions in a longitudinal analysis of the French DESIR cohortQ44808917
Updated risk factor values and the ability of the multivariable risk score to predict coronary heart diseaseQ45026853
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.Q45230526
A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart StudyQ46530577
Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular StudyQ46700751
Trends and geographical disparities in coronary heart disease in France: are results concordant when different definitions of events are used?Q50656460
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.Q51922378
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper.Q51981696
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohortsQ52017724
Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study.Q52082107
An updated coronary risk profile. A statement for health professionals.Q52461335
Estimation of CHD risk in a French working population using a modified Framingham modelQ56788609
Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME StudyQ57605872
Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year follow-upQ63283501
The seven countries study: 2,289 deaths in 15 yearsQ71404923
The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in EuropeQ74152265
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)61-65
P577publication date2008-03-10
P1433published inPreventive MedicineQ7242397
P1476titleTen-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort
P478volume47

Reverse relations

cites work (P2860)
Q33691318A coronary heart disease prediction model: the Korean Heart Study.
Q51227849External validation of the 2008 Framingham cardiovascular risk equation for CHD and stroke events in a European population of middle-aged men. The PRIME study.
Q51583909Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R., Three City, PRIME, and SU.VI.MAX studies.
Q26772283Reassessing the Usefulness of Coronary Artery Calcium Score among Varying Racial and Ethnic Groups by Geographic Locations: Relevance of the Korea Initiatives on Coronary Artery Calcification Registry
Q51759238SCORE should be preferred to Framingham to predict cardiovascular death in French population.
Q39800987Ten-year risk of all-cause mortality: assessment of a risk prediction algorithm in a French general population
Q59808811The challenge of asymptomatic coronary artery disease in aircrew; detecting plaque before the accident

Search more.